Regen BioPharma Issues $125,000 in 10% Unsecured Debt
Bitget2026/11/02 11:09- Regen BioPharma issued a $125,000, 10% unsecured promissory note with an 18-month term to Coventry Enterprises on October 27, 2026.
- Coventry retained $12,500 as an original issue discount; proceeds repaid $71,557 of existing convertible debt and accrued interest.
- Principal and $12,500 of guaranteed interest are payable in eight monthly installments of $17,187.50, beginning six months after funding.
- Upon default, Coventry may convert the note into common shares at 90% of the lowest trading price over the preceding 20 trading days.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Crypto prices
More
